beta-lactams has been researched along with ritipenem in 6 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (ritipenem) | Trials (ritipenem) | Recent Studies (post-2010) (ritipenem) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 69 | 7 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoban, DJ | 1 |
Livermore, DM; Yang, Y | 1 |
Chin, NX; Neu, HC | 1 |
Andrews, JM; Danks, G; Wise, R | 1 |
Brughera, M; Dayan, AD; Iatropoulos, MJ; Mazue, G; Newman, AJ; Scampini, G | 1 |
Gotoh, N; Nishino, T; Okamoto, K | 1 |
6 other study(ies) available for beta-lactams and ritipenem
Article | Year |
---|---|
In-vitro activity of a new penem FCE 22101.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1989 |
Interactions of FCE 22101 with class I beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Enzyme Induction; Microbial Sensitivity Tests; Mutation | 1989 |
In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1989 |
Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Carbapenems; Microbial Sensitivity Tests | 1983 |
Urinary bladder hyperplasia in the rat: non-specific pathogenetic considerations using a beta-lactam antibiotic.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydrogen-Ion Concentration; Hyperplasia; Kidney; Lactams; Male; Precancerous Conditions; Rats; Time Factors; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Urine | 1994 |
Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Biological Transport; Carbapenems; Carrier Proteins; Escherichia coli; Humans; Lactams; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa | 2001 |